New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.
A large nationwide study in Taiwan found that patients with autoimmune skin diseases had lower all-cause and cancer-specific mortality following cancer treatment compared with those without these conditions.
A new multicenter trial found that self-injected low-dose triamcinolone using an assistance device was as effective and safe as physician-administered injections for inflammatory acne, with improved outcomes at higher doses for severe lesions.
A clinical trial in healthy adults found that both extra virgin olive oil and petrolatum significantly improved skin hydration and barrier function, with differing effects on water loss and skin cell turnover.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A systematic review and network meta-analysis of clinical trials found that several biologic and small-molecule therapies provided short-term improvement in adults with moderate to severe hidradenitis suppurativa, a chronic inflammatory skin disease.
Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.
A pooled analysis of two phase 3 trials found that a once-daily topical anticholinergic gel significantly improved sweat reduction and symptom severity in patients with axillary hyperhidrosis, with a tolerable safety profile.